Please see Important Safety Information below. Plaque psoriasis (PsO) and psoriatic arthritis (PsA) are lifelong conditions ...

And beyond the physical symptoms, plaque psoriasis also frequently has negative effects on mental health and alters the lifestyle of those living with it. Here are five ways that this skin condition ...

Research shows lifestyle changes like diet, exercise, and smoking cessation can assist with improving psoriasis outcomes and ...

When compared with placebo, vunakizumab is a safe and efficacious treatment for moderate to severe plaque psoriasis among adults.

Skyrizi (risankizumab-rzaa) is a prescription drug that’s used to treat Crohn’s disease, plaque psoriasis, and psoriatic arthritis. Skyrizi can cause side effects that range from mild to serious.

Johnson & Johnson recently rolled out a TV ad that takes aim at a major disparity in dermatology: the fact that people of ...

Many people with plaque psoriasis can control their symptoms by using topical treatments that are applied to the skin. But some people with moderate or severe plaque psoriasis have symptoms that ...

psoriatic arthritis, and adults with chronic moderate-to-severe plaque psoriasis. In clinical trials, the most common adverse effect of this treatment was injection site reaction (ISR).

Exacerbations of the chronic and progressive inflammatory disease bronchiectasis can impact quality of life. Treatment, based ...

First-of-its-kind Phase 3b study shows TREMFYA ® achieved statistical significance across all primary and secondary endpoints in low body surface area psoriasis with special site involvement ...

Examples include infections, headache, and fatigue. It can also be used to treat plaque psoriasis and psoriatic arthritis in certain children. The active ingredient in Stelara is ustekinumab.